Comparison of Acid-Fast Stain and Auramine Rhodamine Fluorescent Smear on Bronchoalveolar Lavage Specimens Submitted for Cytologic Examination

2019 ◽  
Vol 152 (Supplement_1) ◽  
pp. S128-S128
Author(s):  
Hasan Samra ◽  
Nathan Ledeboer ◽  
Blake Buchan

Abstract Objectives Testing of bronchoalveolar lavage specimens with acid-fast bacilli (AFB) stain is not routinely performed in many institutions. In 2017, we began performing AFB stain on all BAL specimens submitted for cytologic examination. Herein, we evaluate the diagnostic value of this test in comparison to the auramine rhodamine fluorescent stain performed in parallel by the microbiology laboratory for specimens also submitted for AFB culture. Methods We retrospectively reviewed all BAL specimens that were reported as culture positive for Mycobacteria spp. (n = 109) by our microbiology laboratory between 7/20/2017 and 12/30/2018. Of these, 84 (77.0%) specimens were concurrently submitted for cytologic examination and reviewed by a board-certified cytopathologist. Results Of the 84 culture-positive BAL specimens submitted for cytologic exam, only 2 cases were positive for acid-fast bacilli on cytologic examination with AFB stain, yielding a sensitivity of 2.38%. In comparison, 11 of those specimens were identified on auramine rhodamine fluorescent stain, yielding a sensitivity of 13.1%. Both cases identified by the AFB stain on cytology were also identified by auramine rhodamine stain in microbiology. These data indicate that AFB stain conducted in cytology is 81.2% less sensitive for detection of AFB when compared to auramine rhodamine stain. All cases identified on smear and AFB stain (n = 11) belonged to the Mycobacterium avium-intracellulare complex. Conclusion Our study results suggest that in a low-prevalence population, the use of AFB stain on BAL specimens sent for cytologic examination lacks sensitivity and is unnecessary if the same specimen is also sent for microbiologic culture and auramine rhodamine stain. The use of AFB stain on BAL specimens that were not sent for AFB culture is suboptimal but may identify AFB in specimens obtained from patients for whom mycobacterial infection is not in the differential and may be clinically insignificant.

Author(s):  
Parasmal Suresh ◽  
Anil Kumar ◽  
Raja Biswas ◽  
Divya Vijayakumar ◽  
Swathy Thulasidharan ◽  
...  

Nontuberculosis mycobacteria (NTM) are opportunistic pathogens that cause a wide range of illnesses. Here, the species distribution and prevalence of NTM infections in tuberculosis suspects was analyzed. A total of 7,073 specimens from pulmonary and extrapulmonary sites were analyzed, and 709 (10%) were found to be culture positive for mycobacteria. Of these, 85.2% were identified as Mycobacterium tuberculosis complex and 14.8% as NTM (65.7% rapid growers and 34.3% slow growers). Speciation of the NTM isolates (n = 69) identified 19 NTM species. M. abscessus (33.3%) and M. fortuitum (24.6%) were the most dominant NTM species isolated from the patients, followed by M. porcinum (5.8%) and M. parascrofulaceum (4.3%). We also report peritonitis caused by rapidly growing NTM among the patients undergoing continuous ambulatory peritoneal dialysis and a case of M. senegalense peritonitis. A low prevalence but high species diversity of NTM was detected in our study. The high species diversity of NTM necessitates the need to unequivocally identify mycobacterial isolates for appropriate treatment.


Infection ◽  
1993 ◽  
Vol 21 (5) ◽  
pp. 291-296 ◽  
Author(s):  
K. Dalhoff ◽  
J. Braun ◽  
R. Lipp ◽  
K. -J. Wießmann ◽  
H. Hollandt ◽  
...  

CHEST Journal ◽  
1988 ◽  
Vol 93 (2) ◽  
pp. 329-332 ◽  
Author(s):  
J. de Gracia ◽  
V. Curull ◽  
R. Vidal ◽  
A Riba ◽  
R. Orriols ◽  
...  

2010 ◽  
Vol 28 (6) ◽  
pp. 343-352 ◽  
Author(s):  
Yung-Che Chen ◽  
Huang-Chih Chang ◽  
Chung-Jen Chen ◽  
Shih-Feng Liu ◽  
Chien-Hung Chin ◽  
...  

Background and objective:Little is known about the usefulness of lymphocyte subsets as early predictors of anti-tuberculosis (TB) treatment response in immuno-competent patients.Methods:Among a total of 64 patients with culture positive pulmonary TB, 29 remained sputum smear/culture positive or had delayed resolution on CXR (slow responders (SR)), and 35 had sputum culture conversion to negative and rapid resolution on CXR (fast responders (FR)) after two months of anti-tuberculosis treatment. Clinical parameters and lymphocyte subsets were investigated.Results:A larger proportion of patients in the SR group had cavities on CXR, bilateral lung involvement, positive acid-fast bacilli stains, and complaint of cough at diagnosis than those in the FR group. Absolute counts of CD3+T cells (p= 0.016) and CD8+T cells (p= 0.012) at diagnosis were both significantly higher in the SR group. This trend was present throughout the 6-month treatment course. Absolute T cell counts (odds ratio (OR) 1.002, 95% confidence interval (CI) 1.0–1.004), positive sputum acid fast bacilli stain (OR 6.69, 95% CI 1.37–32.77) and bilateral lung involvemment on CXR (OR 13.114, 95% CI 1.87–92.14) at diagnosis were independent predictors for a slow response. Combining these three predictors, a prediction score (PS) could be calculated to display an optimal discrimination for slow response (area under the curve (AUC) = 0.855,p< 0.001) whereas absolute T cell counts yielded the highest discriminative value on an individual level (AUC = 0.676,p= 0.015).Conclusions:A higher T cell count at diagnosis in patients with TB may predict a slow response to two months of treatment. The calculation of a PS further increased predictive accuracy and performance.


2010 ◽  
Vol 42 (10) ◽  
pp. 4415-4420 ◽  
Author(s):  
R. Vos ◽  
B.M. Vanaudenaerde ◽  
S.E. Verleden ◽  
S.I. De Vleeschauwer ◽  
A. Willems-Widyastuti ◽  
...  

2017 ◽  
Vol 24 (3) ◽  
pp. 180 ◽  
Author(s):  
S. Sun ◽  
Z. Chen ◽  
C. Cao ◽  
B. Wu ◽  
B. Wang ◽  
...  

Aim In the present study, we assessed the diagnostic value of epidermal growth factor (egf) and cancer antigens 125 (ca125) and 15-3 (ca15-3) in bronchoalveolar lavage fluid (balf) of lung cancer from 79 enrolled patients with suspected lung cancer.Methods All patients underwent fibrescopic examination, during which balf samples were collected. Levels of egf, ca125, and ca15-3 were determined in balf using commercially available test kits.Results The results showed that levels of egf in balf were significantly higher in patients with lung cancer than in patients with benign diseases (p < 0.01); no significant differences for ca125 (p = 0.67) or ca15-3 (p = 0.43) in balf were observed between the lung cancer patients and the non-cancer control subjects. With a cut-off value of 27.22 pg/mL, egf showed a sensitivity of 63.6% and a specificity of 65.7% in predicting the malignant nature of pulmonary disease.Conclusions The study findings suggest that levels of egf are significantly increased in balf from patients with lung cancer than in balf from patients with benign disease. Detection of the level of egf in balf is proposed as a non-invasive test to identify patients at high risk for lung cancer.


CHEST Journal ◽  
1993 ◽  
Vol 103 (6) ◽  
pp. 1720-1724 ◽  
Author(s):  
Marjolein Drent ◽  
Heleen van Velzen-Blad ◽  
Michaela Diamant ◽  
Sjoerd S. Wagenaar ◽  
Mona Donckerwolcke-Bogaert ◽  
...  

Author(s):  
Markus Unnewehr ◽  
Felix Luecker ◽  
Patricia Bartsch ◽  
Bernhard Schaaf

Sign in / Sign up

Export Citation Format

Share Document